Key Record Dates
| ClinicalTrials.gov Identifier: | NCT04895436 |
|---|---|
| Brief Title: | Study to Assess Change in Disease Activity and Adverse Events of Oral Venetoclax With Intravenous (IV) Obinutuzumab in Adult Participants With Recurring Chronic Lymphocytic Leukemia (CLL) (ReVenG) |
| First Submitted : | May 19, 2021 |
| First Submitted that Met QC Criteria : | May 19, 2021 |
| First Posted : | May 20, 2021 |
| Last Update Submitted that Met QC Criteria : | May 3, 2024 |
| Last Update Posted : | May 6, 2024 |